Once-weekly fluconazole in the treatment of onychomycosis: introduction

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

The British journal of dermatology·2020

Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Human polyomavirus-7-associated eruption successfully treated with acitretin.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.

Mycoses·2017

Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2011

Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group.

Journal of the European Academy of Dermatology and Venereology : JEADV·2010

Janus Kinase Inhibitor Use in Adults Aged 65 Years and Older: A Clinical Review Across Atopic Dermatitis, Alopecia Areata, and Psoriasis.

Journal of the American Academy of Dermatology·2026

Real-World Systemic Treatment Outcomes for Moderate-to-Severe Atopic Dermatitis in Children by Skin Color: 4-Year Results from the observational, international, real-world PEDISTAD Registry.

Journal of the American Academy of Dermatology·2026

Antibiotic Prophylaxis for Dermatologic Surgery. Part 1: Indications, Guidelines, and Special Populations.

Journal of the American Academy of Dermatology·2026

Dermatological Manifestations of Emergent Viruses. Part II: Vector-Borne and Opportunistic Viral Infections.

Journal of the American Academy of Dermatology·2026

Precision acupuncture for chemotherapy-induced peripheral neuropathy: multitarget mechanisms and integrated clinical translation framework.

Frontiers in neurology·2026

Chiliadenus iphionoides ethanolic extract suppresses hepatocellular carcinoma cell survival through ROS-associated mitochondrial dysfunction and intrinsic apoptotic signaling in p53-null Hep3B cells.

Frontiers in medicine·2026

Antifungal pulse therapy for onychomycosis: a narrative review.

European journal of clinical pharmacology·2026

Comparative efficacy and safety of hydrocortisone-based regimens in septic shock: A network meta-analysis.

Journal of critical care·2026

Implementation and Resource Optimization of an Oral Anticancer Medication Clinical Pharmacy Trainee Program: Operational and Financial Impact at a Tertiary Cancer Centre.

Current oncology (Toronto, Ont.)·2026

Discontinuation of nucleos(t)ide analog therapy in hepatitis B e antigen-negative non-cirrhotic chronic hepatitis B patients: A real-life study.

World journal of virology·2026

Related Experiment Videos

Once-weekly fluconazole in the treatment of onychomycosis: introduction

Related Concept Videos

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial.

Human polyomavirus-7-associated eruption successfully treated with acitretin.

Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.

Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.

Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group.

Janus Kinase Inhibitor Use in Adults Aged 65 Years and Older: A Clinical Review Across Atopic Dermatitis, Alopecia Areata, and Psoriasis.

Real-World Systemic Treatment Outcomes for Moderate-to-Severe Atopic Dermatitis in Children by Skin Color: 4-Year Results from the observational, international, real-world PEDISTAD Registry.

Antibiotic Prophylaxis for Dermatologic Surgery. Part 1: Indications, Guidelines, and Special Populations.

Dermatological Manifestations of Emergent Viruses. Part II: Vector-Borne and Opportunistic Viral Infections.

Precision acupuncture for chemotherapy-induced peripheral neuropathy: multitarget mechanisms and integrated clinical translation framework.

Chiliadenus iphionoides ethanolic extract suppresses hepatocellular carcinoma cell survival through ROS-associated mitochondrial dysfunction and intrinsic apoptotic signaling in p53-null Hep3B cells.

Antifungal pulse therapy for onychomycosis: a narrative review.

Comparative efficacy and safety of hydrocortisone-based regimens in septic shock: A network meta-analysis.

Implementation and Resource Optimization of an Oral Anticancer Medication Clinical Pharmacy Trainee Program: Operational and Financial Impact at a Tertiary Cancer Centre.

Discontinuation of nucleos(t)ide analog therapy in hepatitis B e antigen-negative non-cirrhotic chronic hepatitis B patients: A real-life study.

Related Experiment Videos

Once-weekly fluconazole in the treatment of onychomycosis: introduction

Related Concept Videos

Related Articles